BioCentury
ARTICLE | Tools & Techniques

Manufacturing roundup: Deerfield launches new CDMO, plus a gene/cell therapy JV and more

Biotechs, academics turn to partnerships to overcome manufacturing barriers to gene and cell therapies

January 25, 2020 1:43 AM UTC

Manufacturing remains a major hurdle for companies pursuing gene and cell therapies, and as more products make it to market, the bottleneck could create problems with commercial supply.

At least seven manufacturing deals and site launches in January underscore different techniques companies and academics are employing in order to break through the capacity constraints for gene and cell therapies...



Access The Full Article